OICR & Princess Margaret: Changing the World with NovaSeq™ X Plus

28 November 2023

The Ontario Institute for Cancer Research (OICR) is working to better understand tumor biology and improve cancer care through the use of genomics. Their partner at Princess Margaret Cancer Centre, relies on OICR and whole-genome and transcriptome data to guide treatment and monitor disease progression as part of clinical trials. At the core of this, is the sequencing performed on the NovaSeq™ X Plus. Learn how OICR is using the NovaSeq™ X Plus to accelerate projects, like those with Dr. Stephanie Lheureux at Princess Margaret. The economics, speed, and throughput are ultimately aiding both institutions in reaching their organizational goals and missions. Video Chapters: 0:00 – The search for answers 0:35 - Meet Dr. Stephanie Lheureux 0:51 - Meet Dr. Bernard Lam 1:16 - Dr. Laszlo Radvanyi shares an overview of OICR 1:42 - How OICR and Princess Margaret collaborate 2:52 - Working with the NovaSeq™ X Plus 3:12 - The cancer genome and a brighter future for treatment Learn more about the NovaSeq™ X Plus: https://www.illumina.com/systems/sequencing-platforms/novaseq-x-plus/applications/broad-sequencing.html Disclaimer: For research use only. Not for use in diagnostic procedures. Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM Facebook: https://www.facebook.com/illuminainc LinkedIn: https://www.linkedin.com/company/illu... Instagram: https://www.instagram.com/illuminainc/ Twitter: https://twitter.com/illumina #NovaSeqX #OICR #PrincessMargaret

Share this article on    
    
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.